News

American Council on Science and Health1d
Possible New Era in Pain Management: FDA Approves Novel Non-Opioid Analgesic
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
pharmaphorum1y
Vertex scores double win with non-opioid pain drug
Vertex's candidate, called VX-548, targets NaV1.8 sodium channels, which are thought to play a role in relaying pain signals to the spinal cord from peripheral nerves. It has been shown to be ...
Hosted on MSN12mon
Vertex’s pain drug suzetrigine advances in FDA approval process
Vertex Pharmaceuticals’ suzetrigine, previously named VX-548, is steadily advancing along its rolling submission approval pathway okayed by the US Food and Drug Administration (FDA) for moderate ...
Morningstar17d
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
In January Vertex won Food and Drug Administration approval for VX-548, Journavx® (suzetrigine) its non-opioid drug for acute pain Suzetrigine. The company now sports a market capitalization of $ ...